These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 28718029)
81. Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries. Siegal DM; Eikelboom JW; Lee SF; Rangarajan S; Bosch J; Zhu J; Yusuf S; Cardiovasc Res; 2021 Jan; 117(2):576-584. PubMed ID: 32142099 [TBL] [Abstract][Full Text] [Related]
82. Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism. Jiménez-Alcázar M; Limacher A; Panda R; Méan M; Bitterling J; Peine S; Renné T; Beer JH; Aujesky D; Lämmle B; Fuchs TA PLoS One; 2018; 13(2):e0191150. PubMed ID: 29474368 [TBL] [Abstract][Full Text] [Related]
83. Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies. Kunutsor SK; Mäkikallio TH; Seidu S; de Araújo CGS; Dey RS; Blom AW; Laukkanen JA Eur J Epidemiol; 2020 May; 35(5):431-442. PubMed ID: 31728878 [TBL] [Abstract][Full Text] [Related]
85. Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII. Olivieri O; Turcato G; Moruzzi S; Castagna A; Girelli D; Pizzolo F; Friso S; Sandri M; Bassi A; Martinelli N J Am Heart Assoc; 2019 Jan; 8(2):e010973. PubMed ID: 30646800 [TBL] [Abstract][Full Text] [Related]
86. The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study. Frischmuth T; Tøndel BG; Brækkan SK; Hansen JB; Morelli VM Thromb Haemost; 2024 Mar; 124(3):239-249. PubMed ID: 37549694 [TBL] [Abstract][Full Text] [Related]
87. Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies. Nazarzadeh M; Bidel Z; Mohseni H; Canoy D; Pinho-Gomes AC; Hassaine A; Dehghan A; Tregouet DA; Smith NL; Rahimi K; Cardiovasc Res; 2023 May; 119(3):835-842. PubMed ID: 36031541 [TBL] [Abstract][Full Text] [Related]
88. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Pirro M; Bergeron J; Dagenais GR; Bernard PM; Cantin B; Després JP; Lamarche B Arch Intern Med; 2001 Nov; 161(20):2474-80. PubMed ID: 11700160 [TBL] [Abstract][Full Text] [Related]
89. Ultra-processed food intake and incident venous thromboembolism risk: Prospective cohort study. Yuan S; Chen J; Fu T; Li X; Bruzelius M; Åkesson A; Larsson SC Clin Nutr; 2023 Aug; 42(8):1268-1275. PubMed ID: 37348154 [TBL] [Abstract][Full Text] [Related]
90. Resting heart rate and incident venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis. Awotoye J; Fashanu OE; Lutsey PL; Zhao D; O'Neal WT; Michos ED Open Heart; 2020; 7(1):e001080. PubMed ID: 32153786 [TBL] [Abstract][Full Text] [Related]
92. Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study. Lerstad G; Brodin EE; Svartberg J; Jorde R; Brox J; Brækkan SK; Hansen JB Eur J Endocrinol; 2017 May; 176(5):625-634. PubMed ID: 28246149 [TBL] [Abstract][Full Text] [Related]
93. C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study. Grimnes G; Isaksen T; Tichelaar YIGV; Brox J; Brækkan SK; Hansen JB Haematologica; 2018 Jul; 103(7):1245-1250. PubMed ID: 29674505 [TBL] [Abstract][Full Text] [Related]
94. Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study. Arenas de Larriva AP; Alonso A; Norby FL; Roetker NS; Folsom AR J Thromb Haemost; 2019 May; 17(5):818-826. PubMed ID: 30803124 [TBL] [Abstract][Full Text] [Related]
95. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. Kubota Y; McAdams-DeMarco M; Folsom AR Thromb Res; 2016 Aug; 144():144-8. PubMed ID: 27337701 [TBL] [Abstract][Full Text] [Related]
96. Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. Ageno W; Di Minno MN; Ay C; Jang MJ; Hansen JB; Steffen LM; Vayà A; Rattazzi M; Pabinger I; Oh D; Di Minno G; Braekkan SK; Cushman M; Bonet E; Pauletto P; Squizzato A; Dentali F Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2478-85. PubMed ID: 25212233 [TBL] [Abstract][Full Text] [Related]
97. Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review. Galeano-Valle F; Ordieres-Ortega L; Oblitas CM; Del-Toro-Cervera J; Alvarez-Sala-Walther L; Demelo-Rodríguez P Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807848 [TBL] [Abstract][Full Text] [Related]
98. Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis. Ding J; Yue X; Tian X; Liao Z; Meng R; Zou M Thromb J; 2023 Jul; 21(1):82. PubMed ID: 37525162 [TBL] [Abstract][Full Text] [Related]
99. Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature. Dentali F; Gessi V; Marcucci R; Gianni M; Grandi AM; Franchini M Semin Thromb Hemost; 2017 Sep; 43(6):614-620. PubMed ID: 28346964 [TBL] [Abstract][Full Text] [Related]
100. Serum C-reactive protein-to-albumin ratio is a potential risk indicator for pneumonia: Findings from a prospective cohort study. Kunutsor SK; Laukkanen JA Respir Med; 2022 Aug; 199():106894. PubMed ID: 35659744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]